New Direction

Unlocking an entirely new space within drug science based on our proprietary platform

pill

ROLE OF PRM-BINDING PROTEIN DOMAINS

Only a minor fraction of the proteome is considered as druggable

Proline-rich motif (PRM) mediated interactions are the most frequent type of protein-protein interaction in our organism.

They are fundamental drivers of cellular malfunctions resulting in e.g. cancer cell migration, fibrosis as well as in bacterial and viral pathogenesis.

selected targets

YAP1

ONCOLOGY
CARDIOVASCULAR DIEASES
YAP1

ENA/VASP

ONCOLOGY
INFECTIOUS DIEASES
ENA/VASP

CD2BP2

ONCOLOGY
IMMUNE MEDIATED DISORDERS
CD2BP2

FYN

NEURODEGENRATIVE DISEASES
FYN

The challenge to unlock this undruggable class of targets lies in the unique helical structure they are specialized in recognizing. Until now, all attempts to mimic this specific shape with small molecules have failed.

That is exactly where our technology comes into play.

Unlocking PRM-binding domains

THE SCIENCE BEHIND PROM'S

Meet ProM

Mimicking the complex 3D-structure of PRMs

Mimicking the complex 3D-structure of PRMs

ProMs are the first and currently only mimetics of the left-handed poly-L-proline type-II (PPII) Helix - the preferentially adopted conformation of proline-rich motifs (PRM) in protein domains.

Meet ProM

selected targets

We combine our ProMs with our Development Platform to build a diversified pipeline of high value assets.

Step 1

Generating

Based on our modular synthetic approach we are able to fast-track the generation of ProM-based low molecular weight inhibitors for a target of choice

mission

pipeline

developement progress

DRP010Oncology
DRP020Infectious disease
DRP030CNS
DRP040Anti-depressant
DRP050Steroids

Ongoing

Halted

We Illuminate the future of Drug Discovery through AI/ML.

get in touch.